Delivery Order SPE2DB22D2007-SPE2DB25FJ0MT
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$8.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,937.19 firm fixed-price contract is for the delivery of MAVYRET 100-40MG 84S, a pharmaceutical product, to support defense medical supply requirements. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,232.50 firm fixed-price contract is for the provision of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with a period of performance through March 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,232.50 firm fixed-price delivery order is for the supply of 4,568,173,815 units of the prescription medication MAVYRET 100-40 MG TABLET 84S. The contract has a performance period through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,232.50 firm fixed-price delivery order is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with a period of performance running through January 14, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a $23,166.89 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 84-count packs of the drug MAVYRET 100-40 MG tablets. The order has a completion date of July 31, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to provide a wide range of pharmaceutical and medical products to support military...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MAVYRET 100-40 MG TABLET 84S. The contract has a completion date of February 15, 2024 and a potential value of $20,141.12. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and has previously received other federal contracts from DLA Troop Support Medical to supply...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The contract, valued at $14,595.54, is for the delivery of Mavyret 100-40 mg tablets, a specialty medication used to treat hepatitis C. The contract has a period of performance ending on August 9, 2021 and was awarded on a firm fixed-price basis without any set-aside designations. AmerisourceBergen Drug Corp is a subsidiary of the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Mavyret 100-40 mg tablets. The contract, with a ceiling value of $43,274.24, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen to provide pharmaceutical and medical supplies to the DLA Troop Support Medical. The contract has no set-aside designation and is expected to be completed by August 19, 2024. AmerisourceBergen, a major...
This is a $5,454.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 13, 2025 and is not set aside. Amerisourcebergen Drug Corp is supplying a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide through this delivery order. The company holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $3,643.75 Firm Fixed Price delivery order is for the supply of VEMLIDY 25 MG TABLET in a 30-count package. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...